Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays February 2, 2021 Read More
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021 January 13, 2021 Read More
Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results January 7, 2021 Read More
Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference January 6, 2021 Read More
Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2 December 16, 2020 Read More
Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay December 8, 2020 Read More
Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers December 3, 2020 Read More
Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference November 23, 2020 Read More
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum November 16, 2020 Read More
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance November 13, 2020 Read More
